PredxBio Email Format
Biotechnology ResearchPennsylvania, United States11-50 Employees
PredxBio is a biotechnology research company based in Pittsburgh, Pennsylvania, that focuses on organzing tumor biopsy data through AI-driven analysis to derive tissue-based biomarkers. Its platform aims to translate complex tumor biology into actionable insights for oncology drug discovery, translational research, and clinical development, helping pharmaceutical partners understand mechanisms of response and resistance and informing biomarker-driven trial design. The business targets pharmaceutical and biotechnology partners engaged in cancer research and development, providing end-to-end support for tissue quality control, spatial analysis, biomarker discovery, and translational deployment. Established as a member of the broader spatial biology field, PredxBio positions itself around integrating spatial analytics with multi-omic data to illuminate cellular interactions and the tumor microenvironment. Recent activity includes the launch of an enhanced SpaceIQ platform and participation in industry events, reflecting ongoing efforts to expand its capabilities in high-resolution, multi-omics tissue analysis.